The Only FDA Approved Accommodating IOL


Sustained Vision Quality


        • The Crystalens AO brings together Bausch & Lomb’s innovative accommodating lens technology and its proven aspheric lens design
        • This accommodating aspheric IOL is designed to deliver premium vision at all distances without any vision compromise
        • Because the Crystalens AO is aberration free, patients can enjoy best-potential vision quality with enhanced contrast sensitivity

Sustained Vision Quality

  • The Crystalens AO is designed to be free of spherical aberration for better vision quality relative to standard spherical IOLs.1
  • More predictable and repeatable refractive outcomes with a broader patient population can be expected.2
  • Optical performance is unaffected by pupil size or location of the optic due to uniform center-to-edge power.1,2


  • Patients should experience their best-potential postoperative vision quality with enhanced contrast sensitivity, particularly important in low-light or nighttime conditions
  • The Crystalens AO is optimized for lifestyle vision, so objects at intermediate distances are as clear as objects that are near or far

In a study of modulation transfer function (MTF) using a 3 mm aperture, Crystalens AO demonstrated enhanced resolution.

  • Quality of vision is defined by the height of the curve at plano
  • The Crystalens AO is the closest to ideal
  • All IOL measurements are made at a 3 mm aperture, per the ISO 11979-2 standard
  • The Crystalens HD™ and Crystalens Five-O™ show improved MTF performance over multifocal lenses
  • The monofocal accommodating IOLs demonstrate superior vision quality

 

Reference
1. Laboratory data on file at Bausch & Lomb Incorporated.
2. Altmann GE, Nichamin LD, Lane SS, et al. Optical performance of 3 intraocular lens designs in the presence of decentration. J Cataract Refract Surg. 2005;31(3):574-85.